Fairfield Financial Advisors’s Boston Scientific BSX Stock Holding History

Fairfield Financial Advisors’s Portfolio BSX Stock Details BSX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$330K	Sell	5,266 -100	-2%	-$8K	0.11%	64
2025 Q4	$512K	Buy	5,366 +150	+3%	+$14.7K	0.17%	55
2025 Q3	$509K	Buy	5,216 +2,575	+98%	+$267K	0.17%	54
2025 Q2	$284K	Buy	2,641 +45	+2%	+$4.55K	0.1%	66
2025 Q1	$262K	Buy	2,596 +1,996	+333%	+$201K	0.1%	64
2024 Q4	$53.6K	Buy	+600	New	+$52.8K	0.02%	110

Other funds holding BSX

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Fairfield Financial Advisors's BSX Position: Q1 2026 in Review

Fairfield Financial Advisors reduced its Boston Scientific (BSX) stake by 1.9% in Q1 2026, selling an estimated $8K and leaving 5,266 shares worth $330K. The position accounts for 0.11% of the portfolio, ranked #64.

Fairfield Financial Advisors first reported a position in BSX in Q4 2024 and has held it in 6 quarters since. The position peaked at $512K in Q4 2025. 1,664 funds tracked by Wall St. Rank hold BSX as of Q1 2026.

Fairfield Financial Advisors held 5,266 shares of Boston Scientific worth $330K as of Q1 2026.
Fairfield Financial Advisors sold 100 Boston Scientific shares in Q1 2026, an estimated $8K.
Boston Scientific made up 0.11% of Fairfield Financial Advisors's portfolio in Q1 2026, its #64 holding.
Fairfield Financial Advisors first reported a position in Boston Scientific in Q4 2024 and has held it in 6 quarters since.
Fairfield Financial Advisors's Boston Scientific position peaked at $512K in Q4 2025.
1,664 funds tracked by Wall St. Rank held Boston Scientific as of Q1 2026.

Based on Fairfield Financial Advisors's 13F filing for Q1 2026, filed 27 Apr 2026.